In such cases, apart from the few morphological tips suggested by Mostofi et al. [8], the differential diagnosis between primary and secondary bladder cancer relies on other immunohistochemical markers, particularly GCDFP-15, which has high specificity but low sensitivity. This evidence concerns the gene PIP and urinary bladder carcinoma.